IHS Chemical Week

Regions :: India/Pakistan

API business of Dr. Reddy’s reports fall in sales

5:40 AM MDT | July 30, 2014 | Deepti Ramesh

The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 5.6% fall in sales in the company’s fiscal first quarter, ended 30 June, compared with the year-ago quarter, to 5.53 billion Indian rupees ($92 million). Earnings figures for the PSAI business have not been disclosed. Europe accounted for about 48% of the company's PSAI sales in the first quarter, North America accounted for 10%, India accounted for 14%, and the rest of the world accounted for 28%, Dr. Reddy’s says. During...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa